These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9730223)

  • 1. A rational strategy for enhancing the affinity of vancomycin towards depsipeptide ligands.
    Axelsen PH; Li D
    Bioorg Med Chem; 1998 Jul; 6(7):877-81. PubMed ID: 9730223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants for differential effects on D-Ala-D-lactate vs D-Ala-D-Ala formation by the VanA ligase from vancomycin-resistant enterococci.
    Lessard IA; Healy VL; Park IS; Walsh CT
    Biochemistry; 1999 Oct; 38(42):14006-22. PubMed ID: 10529248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconstructing vancomycin.
    Walsh C
    Science; 1999 Apr; 284(5413):442-3. PubMed ID: 10232990
    [No Abstract]   [Full Text] [Related]  

  • 4. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
    Ge M; Chen Z; Onishi HR; Kohler J; Silver LL; Kerns R; Fukuzawa S; Thompson C; Kahne D
    Science; 1999 Apr; 284(5413):507-11. PubMed ID: 10205063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural biology of molecular recognition by vancomycin.
    Loll PJ; Axelsen PH
    Annu Rev Biophys Biomol Struct; 2000; 29():265-89. PubMed ID: 10940250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of configurational entropy in biochemical cooperativity.
    Jusuf S; Loll PJ; Axelsen PH
    J Am Chem Soc; 2002 Apr; 124(14):3490-1. PubMed ID: 11929222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19F NMR in the measurement of binding affinities of chloroeremomycin to model bacterial cell-wall surfaces that mimic VanA and VanB resistance.
    Entress RM; Dancer RJ; O'Brien DP; Try AC; Cooper MA; Williams DH
    Chem Biol; 1998 Jun; 5(6):329-37. PubMed ID: 9653551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers.
    Cooper MA; Fiorini MT; Abell C; Williams DH
    Bioorg Med Chem; 2000 Nov; 8(11):2609-16. PubMed ID: 11092546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding.
    Loll PJ; Kaplan J; Selinsky BS; Axelsen PH
    J Med Chem; 1999 Nov; 42(22):4714-9. PubMed ID: 10579833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin.
    Rao J; Lahiri J; Isaacs L; Weis RM; Whitesides GM
    Science; 1998 May; 280(5364):708-11. PubMed ID: 9563940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
    Ślusarz R; Szulc M; Madaj J
    Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
    Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D
    J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MM 45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-L-lysyl-D-alanyl-D-alanine.
    Good VM; Gwynn MN; Knowles DJ
    J Antibiot (Tokyo); 1990 May; 43(5):550-5. PubMed ID: 2113517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
    Lee JG; Sagui C; Roland C
    J Am Chem Soc; 2004 Jul; 126(27):8384-5. PubMed ID: 15237988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface Ligand Density of Antibiotic-Nanoparticle Conjugates Enhances Target Avidity and Membrane Permeabilization of Vancomycin-Resistant Bacteria.
    Hassan MM; Ranzoni A; Phetsang W; Blaskovich MA; Cooper MA
    Bioconjug Chem; 2017 Feb; 28(2):353-361. PubMed ID: 27959504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycin-resistant Leuconostoc mesenteroides. Effects of a phenylalanine 261 to tyrosine mutation.
    Park IS; Walsh CT
    J Biol Chem; 1997 Apr; 272(14):9210-4. PubMed ID: 9083053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions.
    McComas CC; Crowley BM; Boger DL
    J Am Chem Soc; 2003 Aug; 125(31):9314-5. PubMed ID: 12889959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronized conformational fluctuations and binding site desolvation during molecular recognition.
    Jusuf S; Axelsen PH
    Biochemistry; 2004 Dec; 43(49):15446-52. PubMed ID: 15581356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel glycopeptide antibiotics: N-alkylated derivatives active against vancomycin-resistant enterococci.
    Rodriguez MJ; Snyder NJ; Zweifel MJ; Wilkie SC; Stack DR; Cooper RD; Nicas TI; Mullen DL; Butler TF; Thompson RC
    J Antibiot (Tokyo); 1998 Jun; 51(6):560-9. PubMed ID: 9711219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of oritavancin and related glycopeptide antibiotics.
    Allen NE; Nicas TI
    FEMS Microbiol Rev; 2003 Jan; 26(5):511-32. PubMed ID: 12586393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.